Literature DB >> 19169915

A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques.

Safora Johansen1, Luca Cozzi, Dag Rune Olsen.   

Abstract

PURPOSE: To investigate the impact of using different radiation therapy techniques on contra-lateral breast (CB) dose, and also dose to other involved organs at risk such as heart and lungs following radiation therapy of breast and regional lymph nodes. Furthermore, to predict the risk for induced malignancies in CB using linear and non linear models.
MATERIAL AND METHODS: Eight patients with stage II-III breast cancer were included in this analysis. It was focused on three treatment techniques; conventional radiotherapy technique forwardly planed, IMRT and volumetric modulated arc (RapidArc) techniques, inversely planed. The CC algorithm was employed to calculate the standard treatment plans whereas for the IMRT and RapidArc treatment plans AAA algorithm was adopted. The dose results based on mostly DVH analysis were compared. The excess relative risk (ERR) for cancer induction in CB, employed both linear and non-linear models, was estimated.
RESULTS: A better homogeneity and conformation in PTV was observed in the RapidArc plans. The highest minimum dose to PTV was observed in the conventional plans while no difference was observed for minimum significant doses D(98%) and D(99%) where D(X%) is the dose received by X% of the PTV volume. In terms of organ sparing, the IMRT and RapidArc plans spare ipsilateral-lung better, but a 40% lower mean dose in the contra-lateral lung in the conventional plans is observed. The mean dose to the contra-lateral breast was lowest for the RapidArc plans as well as the V(10Gy) and the maximum dose. The mean predicted ERR for the eight patients were lower for the conventional and RA plans than for the IMRT plans assuming a linear dose-risk relationship. The mean predicted ERR when using a non linear model was lower for all the three techniques (with lowest ERR for RapidArc plans).
CONCLUSIONS: From a clinical perspective, it should be concluded that all three solutions investigated in the study can offer high quality treatment of patients. Further comparative analysis of the two algorithms used in the present study, however, should be performed especially on the peripheral organ dose. The impact of CB exposure to a low-dose radiation on minimizing the risk of radiation induced malignancy in CB can be interpreted differently when using linear or non linear models to predict ERR. In general, no detriment was observed when using RapidArc compared to conventional treatments while a potentially higher risk could be associated to IMRT treatments with fixed gantry.

Entities:  

Mesh:

Year:  2009        PMID: 19169915     DOI: 10.1080/02841860802657227

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  31 in total

1.  Dosimetric comparison of the field-in-field technique and tangential wedged beams for breast irradiation.

Authors:  Cem Onal; Aydan Sonmez; Gungor Arslan; Ezgi Oymak; Ayse Kotek; Esma Efe; Serhat Sonmez; Yemliha Dolek
Journal:  Jpn J Radiol       Date:  2011-12-21       Impact factor: 2.374

Review 2.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

3.  Chest wall radiotherapy with volumetric modulated arcs and the potential role of flattening filter free photon beams.

Authors:  S Subramaniam; S Thirumalaiswamy; C Srinivas; G A Gandhi; M Kathirvel; K K Kumar; S Mallik; M Babaiah; Y Pawar; A Clivio; A Fogliata; P Mancosu; G Nicolini; E Vanetti; L Cozzi
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

4.  Dosimetric trade-offs in breast treatment with VMAT technique.

Authors:  Antonella Fogliata; Jan Seppälä; Giacomo Reggiori; Francesca Lobefalo; Valentina Palumbo; Fiorenza De Rose; Davide Franceschini; Marta Scorsetti; Luca Cozzi
Journal:  Br J Radiol       Date:  2017-01-03       Impact factor: 3.039

5.  Second Cancer Risk after simultaneous integrated boost radiation therapy of right sided breast cancer with and without flattening filter.

Authors:  Barbara Dobler; Johannes Maier; Bernadette Knott; Manuel Maerz; Rainer Loeschel; Oliver Koelbl
Journal:  Strahlenther Onkol       Date:  2016-08-17       Impact factor: 3.621

6.  Mammary Chain Irradiation in Left-Sided Breast Cancer: Can We Reduce the Risk of Secondary Cancer and Ischaemic Heart Disease with Modern Intensity-Modulated Radiotherapy Techniques?

Authors:  Vanessa Figlia; Cristoforo Simonetto; Markus Eidemüller; Stefania Naccarato; Gianluisa Sicignano; Antonio De Simone; Ruggero Ruggieri; Rosario Mazzola; Christiane Matuschek; Edwin Bölke; Montserrat Pazos; Maximilian Niyazi; Claus Belka; Filippo Alongi; Stefanie Corradini
Journal:  Breast Care (Basel)       Date:  2020-10-19       Impact factor: 2.268

7.  Mesenchymal stromal cells having inactivated RB1 survive following low irradiation and accumulate damaged DNA: Hints for side effects following radiotherapy.

Authors:  Nicola Alessio; Stefania Capasso; Giovanni Di Bernardo; Salvatore Cappabianca; Fiorina Casale; Anna Calarco; Marilena Cipollaro; Gianfranco Peluso; Umberto Galderisi
Journal:  Cell Cycle       Date:  2016-04-28       Impact factor: 4.534

8.  Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy.

Authors:  H Badakhshi; D Kaul; J Nadobny; B Wille; J Sehouli; V Budach
Journal:  Br J Radiol       Date:  2013-10-28       Impact factor: 3.039

9.  The Composite Planning Technique in Left Sided Breast Cancer Radiotherapy: A Dosimetric Study.

Authors:  Naveen Kumawat; Anil Kumar Shrotriya; Malhotra Singh Heigrujam; Satendra Kumar; Manoj Kumar Semwal; Anil Kumar Bansal; Ram Kishan Munjal; Deepak Kumar Mittal; Charu Garg; Anil Kumar Anand
Journal:  Eur J Breast Health       Date:  2020-04-01

10.  Two years experience with quality assurance protocol for patient related Rapid Arc treatment plan verification using a two dimensional ionization chamber array.

Authors:  Daniela Wagner; Hilke Vorwerk
Journal:  Radiat Oncol       Date:  2011-02-22       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.